Inspection Record

Innomar Strategies Inc — Health Canada Inspection Findings

Health CanadaInspected 2024-07-09 3 findingsStability and storageRegulatory reporting and change controlOther quality system

View the regulator's official source The source document is always the basis for judgement.

Findings

1Stability and storage

The design of the drug stability study was inadequate and/or not justified with a documented rationale.

2Regulatory reporting and change control

The change control system was inadequate for ensuring changes are properly documented, evaluated, and/or approved.

3Other quality system

The retention time for records was inadequate.

About this record

Extracted automatically from the document of the Health Canada inspection on 2024-07-09. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Other records for this company

2024-06-11 · Health Canada · 8 findings2023-03-13 · Health Canada · 7 findings
Innomar Strategies Inc findings history — including this company's other documents Health Canada documents, 2024 Go to Findings search